Table 4 Cellular protein expression in L-SCC compared with OP-SCC and CxCa, in relation to HPV16 status

From: Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma

 

L-SCCHPV DNA− (N =35)

L-SCCHPV16 DNA+ RNA− (N =18)

L-SCCHPV16 RNA+ (N =4)

OP-SCCHPV DNA− (N =93)a

OP-SCCHPV16 DNA+ RNA− (N =55)a

OP-SCCHPV16 RNA+ (N =40)a

CxCaHPV16 RNA+ (N =44)b

Cellular protein expression levels

N (%)

N (%)

N (%)

(%)

(%)

(%)

(%)

p16 INK4a

High

0

0

3 (75)

(14)

(21)

(80)

(98)

Low

35 (100)

18 (100)

1 (25)

(86)

(79)

(20)

(2)

pRb

High

19 (54)

11 (61)

1 (25)

(89)

(82)

(15)

(5)

Low

16 (46)

7 (39)

3 (75)

(11)

(18)

(85)

(95)

CyD1

High

15 (43)

9 (50)

2 (50)

(56)

(54)

(5)

(21)c

Low

20 (57)

9 (50)

2 (50)

(44)

(46)

(95)

(79)c

p53

High

8 (23)

6 (33)

1 (25)

(49)

(62)

(15)

(39)

Low

27 (77)

12 (67)

3 (75)

(51)

(38)

(85)

(61)

p16high/pRblow

0

0

3 (75)

(5)

(8)

(80)

(95)

Other

35 (100)

18 (100)

1 (25)

(95)

(92)

(20)

(5)

  1. This table includes only L-SCC with analysable IHC data for all four proteins (35 of 60 HPV DNA− and 22 of 25 HPV16 DNA+ L-SCC). Non-HPV16 DNA+ cases are not included for better direct comparison with HPV16 DNA+ OP-SCC and CxCa, respectively.
  2. aFrom Holzinger et al (2013).
  3. bFrom Halec et al (2012). Importantly, the protein expression in Holzinger et al (2013) and Halec et al (2012) was assessed using the same antibody references and evaluation criteria.
  4. cIHC results for CyD1 of CxCa series published in Halec et al (2012) are reported here for the first time. Only a small fraction, 14 of 44 HPV16 RNA+ CxCa, had enough tissue material for cyclin D1 analysis. Eleven of these 14 (79%) showed CyD1low expression. Expression of all four proteins was similar across L-SCCHPV DNA− and L-SCCHPV16 DNA+ RNA− groups. Such similarity was also observed among OP-SCCHPV DNA− and OP-SCCHPV16 DNA+ RNA− groups (Holzinger et al, 2013).